1. Home
  2. EVTL vs TRDA Comparison

EVTL vs TRDA Comparison

Compare EVTL & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$1.72

Market Cap

235.6M

Sector

Industrials

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$6.50

Market Cap

268.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
TRDA
Founded
2016
2016
Country
United Kingdom
United States
Employees
454
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.6M
268.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EVTL
TRDA
Price
$1.72
$6.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$12.70
$21.00
AVG Volume (30 Days)
2.0M
345.9K
Earning Date
03-24-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$25,421,000.00
Revenue This Year
N/A
$39.97
Revenue Next Year
N/A
$50.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.37
$4.93
52 Week High
$7.35
$16.45

Technical Indicators

Market Signals
Indicator
EVTL
TRDA
Relative Strength Index (RSI) 44.01 39.92
Support Level $1.62 $5.75
Resistance Level $2.08 $7.02
Average True Range (ATR) 0.14 0.46
MACD 0.01 -0.06
Stochastic Oscillator 47.18 12.04

Price Performance

Historical Comparison
EVTL
TRDA

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: